메뉴 건너뛰기




Volumn 25, Issue 3, 2010, Pages 920-926

Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: A randomized controlled trial

Author keywords

Chronic kidney disease; Haemoglobin; Iron sucrose; Oral iron; Randomized controlled trial

Indexed keywords

CREATININE; FERRIC HYDROXIDE SUCROSE; FERRITIN; FERROUS SULFATE; HEMOGLOBIN; TRANSFERRIN;

EID: 77649212913     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp584     Document Type: Article
Times cited : (15)

References (15)
  • 1
    • 0029952883 scopus 로고    scopus 로고
    • A randomized controlled study of iron supplementation in patients treated with eryth-ropoietin
    • Macdougall IC, Tucker B, Thompson J, et al. A randomized controlled study of iron supplementation in patients treated with eryth-ropoietin. Kidney Int 1996; 50: 1694-1699
    • (1996) Kidney Int , vol.50 , pp. 1694-1699
    • MacDougall, I.C.1    Tucker, B.2    Thompson, J.3
  • 2
    • 0034088831 scopus 로고    scopus 로고
    • Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients
    • Besarab A, Amin N, Ahsan M, et al. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. JASN 2000; 11: 530-538
    • (2000) JASN , vol.11 , pp. 530-538
    • Besarab, A.1    Amin, N.2    Ahsan, M.3
  • 3
    • 0036173106 scopus 로고    scopus 로고
    • Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients
    • Chang CH, Chang CC, Chiang SS. Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients. Clin Nephrol 2002; 57: 136-141
    • (2002) Clin Nephrol , vol.57 , pp. 136-141
    • Chang, C.H.1    Chang, C.C.2    Chiang, S.S.3
  • 4
    • 20944449485 scopus 로고    scopus 로고
    • Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis
    • Charytan C, Qunibi W, Bailie GR. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis. Nephron Clin Pract 2005; 100: c55-c62
    • (2005) Nephron Clin Pract , vol.100
    • Charytan, C.1    Qunibi, W.2    Bailie, G.R.3
  • 5
    • 0035003179 scopus 로고    scopus 로고
    • A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin
    • Stoves J, Inglis H, Newstead CG. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. Nephrol Dial Transplant 2001; 16: 967-974
    • (2001) Nephrol Dial Transplant , vol.16 , pp. 967-974
    • Stoves, J.1    Inglis, H.2    Newstead, C.G.3
  • 6
    • 33747120659 scopus 로고    scopus 로고
    • Using standardized serum cre-atinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
    • Levey AS, Coresh J, Greene T, et al. Using standardized serum cre-atinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254
    • (2006) Ann Intern Med , vol.145 , pp. 247-254
    • Levey, A.S.1    Coresh, J.2    Greene, T.3
  • 7
    • 9144239992 scopus 로고    scopus 로고
    • The role of epoetin alfa in chronic kidney disease: Effects on left ventricular mass and renal function. Results of a prospective randomized trial
    • Roger SD, McMahon LP, Hawley C, et al. The role of epoetin alfa in chronic kidney disease: effects on left ventricular mass and renal function. Results of a prospective randomized trial. J Am Soc Nephrol 2004; 15: 148-156
    • (2004) J Am Soc Nephrol , vol.15 , pp. 148-156
    • Roger, S.D.1    McMahon, L.P.2    Hawley, C.3
  • 8
    • 28544444372 scopus 로고    scopus 로고
    • Caring for Australians with Renal Impairment (CARI). the CARI guidelines. Biochemical and haematolo-gical targets guidelines. Haemoglobin
    • Pollock C, McMahon L. Caring for Australians with Renal Impairment (CARI). The CARI guidelines. Biochemical and haematolo-gical targets guidelines. Haemoglobin. Nephrology 2005; 10: S108-S115
    • (2005) Nephrology , vol.10
    • Pollock, C.1    McMahon, L.2
  • 9
    • 29044436900 scopus 로고    scopus 로고
    • A review of the updated European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure
    • Jenkins K. A review of the updated European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. EDTNA-ERCA J 2005; 31: 156-159
    • (2005) EDTNA-ERCA J , vol.31 , pp. 156-159
    • Jenkins, K.1
  • 10
    • 34548046760 scopus 로고    scopus 로고
    • NKF KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease 2007 update of hemoglobin target
    • NKF KDOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease, 2007 update of hemoglobin target. Am J KidneyDis 2007 September Supplement (available on-line at: www.kdoqi.org)
    • Am J KidneyDis 2007 September Supplement
  • 11
    • 32844465284 scopus 로고    scopus 로고
    • A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD
    • Van Wyck DB, Roppolo M, Martinez CO, et al. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney Int 2005; 68: 2846-2856
    • (2005) Kidney Int , vol.68 , pp. 2846-2856
    • Van Wyck, D.B.1    Roppolo, M.2    Martinez, C.O.3
  • 12
    • 0035100648 scopus 로고    scopus 로고
    • The effect of IV iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period
    • Silverberg DS, Blum M, Agbaria Z, et al. The effect of IV iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Clin Nephrol 2001; 3: 212-219
    • (2001) Clin Nephrol , vol.3 , pp. 212-219
    • Silverberg, D.S.1    Blum, M.2    Agbaria, Z.3
  • 13
    • 0030019635 scopus 로고    scopus 로고
    • Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis
    • Silverberg DS, Iaina A, Peer G, et al. Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am J Kidney Dis 1996; 27: 234-238
    • (1996) Am J Kidney Dis , vol.27 , pp. 234-238
    • Silverberg, D.S.1    Iaina, A.2    Peer, G.3
  • 14
    • 49649099818 scopus 로고    scopus 로고
    • Ferumoxytol for treating iron deficiency anemia in CKD
    • Spinowitz BS, Kausz AT, Baptista J, et al. Ferumoxytol for treating iron deficiency anemia in CKD. J Am Soc Nephrol 2008; 19: 1599-1605
    • (2008) J Am Soc Nephrol , vol.19 , pp. 1599-1605
    • Spinowitz, B.S.1    Kausz, A.T.2    Baptista, J.3
  • 15
    • 30344449168 scopus 로고    scopus 로고
    • Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients
    • Mircescu G, Garneata L, Capusa C, et al. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients. Nephrol Dial Transplant 2006; 21: 120-124
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 120-124
    • Mircescu, G.1    Garneata, L.2    Capusa, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.